Salgi Esophageal Cancer Research Foundation

Analysis

Salgi Esophageal Cancer Research Foundation is a registered charity in United States, based in E Greenwich, RI. It received its IRS tax-exemption ruling in February 2012, 14 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending November 2023, Salgi Esophageal Cancer Research Foundation reported income of $101k and spending of $147k, spending 146% of what it took in. Across the 4 years on record, from November 2019 to November 2023, income grew from $93k to $101k (+7.8%), an average of +2.5% a year. The sharpest change came in the year to November 2022, when income rose by 51%. Over the whole period it spent 46% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Salgi Esophageal Cancer Research Foundation sits at the 28th percentile: it is larger than about 28% of them. Against every charity in United States with reported income it ranks in the 37th percentile, and in the 33rd percentile within RI. Charities of a similar size with the same main cause include Josefa Perez de Castano Kidney Foundation Inc ($101k), CGD Association of America Inc ($101k) and Doctors Hospital ($101k).

On its Form 990 for the period ending November 2023, revenue came from contributions and grants 100% of the total. Compensation of current officers, directors and key employees was $9,443 (6.4% of expenses). At year end it held assets of $508k against liabilities of $0, net assets of $508k. It reported 1 employees.